Jason I. Herschkowitz

9.7k total citations · 3 hit papers
49 papers, 4.9k citations indexed

About

Jason I. Herschkowitz is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jason I. Herschkowitz has authored 49 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 21 papers in Oncology and 20 papers in Cancer Research. Recurrent topics in Jason I. Herschkowitz's work include Cancer Cells and Metastasis (16 papers), Cancer-related molecular mechanisms research (16 papers) and Cancer-related Molecular Pathways (9 papers). Jason I. Herschkowitz is often cited by papers focused on Cancer Cells and Metastasis (16 papers), Cancer-related molecular mechanisms research (16 papers) and Cancer-related Molecular Pathways (9 papers). Jason I. Herschkowitz collaborates with scholars based in United States, Canada and France. Jason I. Herschkowitz's co-authors include Charles M. Perou, Xiaping He, Cheng Fan, Aleix Prat, Olga Karginova, Chad Livasy, Joel S. Parker, Jeffrey M. Rosen, Joseph H. Taube and Sendurai A. Mani and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Bioinformatics.

In The Last Decade

Jason I. Herschkowitz

45 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

2010 1.6k citations Aleix Prat, Joel S. Parker et al. Breast Cancer Research profile →
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes

2010 803 citations Joseph H. Taube, Jason I. Herschkowitz et al. profile →
The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo

2011 473 citations Jason I. Herschkowitz, Jeffrey M. Rosen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jason I. Herschkowitz United States	25	3.0k	2.6k	1.9k	581	390	49	4.9k
Nathalie Cervera France	25	2.3k 0.8×	2.1k 0.8×	1.6k 0.8×	400 0.7×	430 1.1×	32	4.2k
Oddbjørn Straume Norway	31	2.8k 0.9×	2.4k 0.9×	1.3k 0.7×	694 1.2×	250 0.6×	69	4.6k
Christine M. Fillmore United States	13	2.7k 0.9×	2.2k 0.8×	1.4k 0.7×	778 1.3×	233 0.6×	16	4.5k
Cristina Nadal Spain	17	2.2k 0.7×	2.3k 0.9×	1.3k 0.7×	726 1.2×	187 0.5×	42	4.3k
Florence Monville France	13	2.9k 1.0×	4.0k 1.5×	2.0k 1.0×	514 0.9×	363 0.9×	17	5.5k
Kristel Kemper Netherlands	23	2.7k 0.9×	2.9k 1.1×	1.1k 0.6×	329 0.6×	354 0.9×	35	4.7k
Zhigang C. Wang United States	16	2.6k 0.9×	1.9k 0.7×	1.1k 0.6×	479 0.8×	536 1.4×	22	3.9k
Jayne M. Stommel United States	20	4.3k 1.4×	2.3k 0.9×	1.7k 0.9×	478 0.8×	192 0.5×	29	6.4k
David Sarrió Spain	28	2.6k 0.9×	2.0k 0.8×	1.3k 0.7×	478 0.8×	398 1.0×	37	4.5k
Hans Skovgaard Poulsen Denmark	44	2.5k 0.8×	2.0k 0.8×	1.2k 0.6×	1.2k 2.0×	486 1.2×	188	5.9k

Countries citing papers authored by Jason I. Herschkowitz

Since Specialization

Citations

This map shows the geographic impact of Jason I. Herschkowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason I. Herschkowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason I. Herschkowitz more than expected).

Fields of papers citing papers by Jason I. Herschkowitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason I. Herschkowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason I. Herschkowitz. The network helps show where Jason I. Herschkowitz may publish in the future.

Co-authorship network of co-authors of Jason I. Herschkowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Jason I. Herschkowitz. A scholar is included among the top collaborators of Jason I. Herschkowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason I. Herschkowitz. Jason I. Herschkowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gong, Xiangyu, et al.. (2021). An Organotypic Mammary Duct Model Capturing Matrix Mechanics-Dependent Ductal Carcinoma In Situ Progression. Tissue Engineering Part A. 27(7-8). 454–466. 4 indexed citations

Sinnott, Rebecca, et al.. (2021). Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer. Breast Cancer Research. 23(1). 101–101. 21 indexed citations

Nguyen, Tuan M., et al.. (2020). New twists on long noncoding RNAs: from mobile elements to motile cancer cells. RNA Biology. 17(11). 1535–1549. 6 indexed citations

Sinnott, Rebecca & Jason I. Herschkowitz. (2018). Beyond DNA: the Role of Epigenetics in the Premalignant Progression of Breast Cancer. Journal of Mammary Gland Biology and Neoplasia. 23(4). 223–235. 21 indexed citations

Sinnott, Rebecca, et al.. (2017). Surface-enhanced Raman scattering investigation of targeted delivery and controlled release of gemcitabine. International Journal of Nanomedicine. Volume 12. 7763–7776. 29 indexed citations

Sinnott, Rebecca, et al.. (2016). Determination of Alternate Splicing Events Using Transcriptome Arrays. Methods in molecular biology. 1507. 245–259. 2 indexed citations

Herschkowitz, Jason I., et al.. (2016). Molecular and Cellular Changes in Breast Cancer and New Roles of lncRNAs in Breast Cancer Initiation and Progression. Progress in molecular biology and translational science. 144. 563–586. 24 indexed citations

Herschkowitz, Jason I., et al.. (2016). Stand-Sit Microchip for High-Throughput, Multiplexed Analysis of Single Cancer Cells. Scientific Reports. 6(1). 32505–32505. 13 indexed citations

Bai, Feng, Ho Lam Chan, Matthew D. Smith, et al.. (2014). BRCA1 Suppresses Epithelial-to-Mesenchymal Transition and Stem Cell Dedifferentiation during Mammary and Tumor Development. Cancer Research. 74(21). 6161–6172. 57 indexed citations

10.

Usary, Jerry, Wei Zhao, David B. Darr, et al.. (2013). Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice. Clinical Cancer Research. 19(17). 4889–4899. 40 indexed citations

11.

Hollier, Brett G., Agata A. Tinnirello, Steven J. Werden, et al.. (2013). FOXC2 Expression Links Epithelial–Mesenchymal Transition and Stem Cell Properties in Breast Cancer. Cancer Research. 73(6). 1981–1992. 220 indexed citations

12.

Herschkowitz, Jason I. & R Lubet. (2011). Mouse models of triple negative [basal-like/claudin low] breast cancer. Breast Disease. 32(1-2). 63–71. 5 indexed citations

13.

Jiang, Zhe, Robert A. Jones, Jeff C. Liu, et al.. (2011). RB1 and p53 at the crossroad of EMT and triple-negative breast cancer. Cell Cycle. 10(10). 1563–1570. 82 indexed citations

14.

Pond, Adam C., Jason I. Herschkowitz, Kathryn L. Schwertfeger, et al.. (2010). Fibroblast Growth Factor Receptor Signaling Dramatically Accelerates Tumorigenesis and Enhances Oncoprotein Translation in the Mouse Mammary Tumor Virus–Wnt-1 Mouse Model of Breast Cancer. Cancer Research. 70(12). 4868–4879. 40 indexed citations

15.

Greene, Stephanie, Jason I. Herschkowitz, & Jeffrey M. Rosen. (2010). The ups and downs of miR-205: Identifying the roles of miR-205 in mammary gland development and breast cancer. RNA Biology. 7(3). 300–304. 77 indexed citations

16.

Jiang, Zhe, Tao Deng, Robert A. Jones, et al.. (2010). Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status. Journal of Clinical Investigation. 120(9). 3296–3309. 116 indexed citations

17.

Prat, Aleix, Joel S. Parker, Olga Karginova, et al.. (2010). Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Research. 12(5). R68–R68. 1575 indexed citations breakdown →

18.

Greene, Stephanie, Jason I. Herschkowitz, & Jeffrey M. Rosen. (2010). Small Players With Big Roles: MicroRNAs as Targets to Inhibit Breast Cancer Progression. Current Drug Targets. 11(9). 1059–1073. 31 indexed citations

19.

Li, Zhe, Cristina E. Tognon, Frank J. Godinho, et al.. (2007). ETV6-NTRK3 Fusion Oncogene Initiates Breast Cancer from Committed Mammary Progenitors via Activation of AP1 Complex. Cancer Cell. 12(6). 542–558. 108 indexed citations

20.

Bultman, Scott J., Jason I. Herschkowitz, Virginia Godfrey, et al.. (2007). Characterization of mammary tumors from Brg1 heterozygous mice. Oncogene. 27(4). 460–468. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact